P

Pharming Group NV

PHAR

8.06000
USD
-0.61
(-7.04%)
Market Closed
Volume
34
EPS
0
Div Yield
0
P/E
-45
Market Cap
581,349,661
News

Title: Pharming Group NV

Sector: Healthcare
Industry: Biotechnology
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.